Changes in Opioid Marketing Practices After Release of the CDC Guidelines

Medicine & Life Sciences

• Marketing 100%
• Centers for Disease Control and Prevention (U.S.) 94%
• Opioid Analgesics 81%
• Guidelines 59%
• Physicians 31%
• Primary Care Physicians 17%
• Primary Health Care 13%
• Interrupted Time Series Analysis 11%
• Prescriptions 7%
• Pharmaceutical Preparations 6%
• Cross-Sectional Studies 5%
• Education 5%
• Databases 5%

Social Sciences

• marketing 74%
• physician 50%
• pharmaceutical 15%
• time series 8%
• cross-sectional study 8%
• medication 7%
• time 5%
• Group 5%
• trend 4%
• education 2%